Dupilumab in the Treatment of Dyshidrosis: A Report of Two Cases of Dyshidrotic Eczema
995199519951
[vc_row][vc_column][vc_column_text]Dyshidrotic eczema (dyshidrosis) primarily appears on the palms and soles and is often difficult to treat. In this Journal of Drugs in Dermatology (JDD) case report, we look at two successfully treated unique cases of recalcitrant dyshidrotic eczema (dyshidrosis). This article was written by Gillian K. Weston MD, Jette Hooper, Bruce E. Strober MD PhD and publish …
[vc_row][vc_column][vc_column_text]Dyshidrotic eczema (dyshidrosis) primarily appears on the palms and soles and is often difficult to treat. In this Journal of Drugs in Dermatology (JDD) case report, we look at two successfully treated unique cases of recalcitrant dyshidrotic eczema (dyshidrosis). This article was written by Gillian K. Weston MD, Jette Hooper, Bruce E. Strober MD PhD and publish … 
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au … 
Question 1
In your JDD podcast interview, you mentioned that about 50-60% of your patients with LPP respond to naltrexone. Have you seen any similarities between these responders that could help dermatologists identify which patients would be good candidates for naltrexone as an adjunctive therapy?
Answer
"No I have not seen any similarities. The response is unpredictable."
Quest … 